Literature DB >> 27297342

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Cecilia C Low Wang1, Connie N Hess1, William R Hiatt1, Allison B Goldfine2.   

Abstract

Cardiovascular disease remains the principal cause of death and disability among patients with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying atherosclerosis and heart failure. Unfortunately, these mechanisms are not adequately modulated by therapeutic strategies focusing solely on optimal glycemic control with currently available drugs or approaches. In the setting of multifactorial risk reduction with statins and other lipid-lowering agents, antihypertensive therapies, and antihyperglycemic treatment strategies, cardiovascular complication rates are falling, yet remain higher for patients with diabetes mellitus than for those without. This review considers the mechanisms, history, controversies, new pharmacological agents, and recent evidence for current guidelines for cardiovascular management in the patient with diabetes mellitus to support evidence-based care in the patient with diabetes mellitus and heart disease outside of the acute care setting.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular diseases; diabetes mellitus; drugs; heart failure; trials

Mesh：

Substances：

Year:  2016        PMID： 27297342      PMCID： PMC4910510          DOI： 10.1161/CIRCULATIONAHA.116.022194

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


  491 in total

Review 1.  The place of sulfonylureas in the therapy for type 2 diabetes mellitus.

Authors:  Stefano Del Prato; Nicolò Pulizzi
Journal:  Metabolism       Date:  2006-05       Impact factor: 8.694

Review 2.  Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.

Authors:  Despoina Vasilakou; Thomas Karagiannis; Eleni Athanasiadou; Maria Mainou; Aris Liakos; Eleni Bekiari; Maria Sarigianni; David R Matthews; Apostolos Tsapas
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

3.  Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Authors:  Florencia Halperin; Su-Ann Ding; Donald C Simonson; Jennifer Panosian; Ann Goebel-Fabbri; Marlene Wewalka; Osama Hamdy; Martin Abrahamson; Kerri Clancy; Kathleen Foster; David Lautz; Ashley Vernon; Allison B Goldfine
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

Review 4.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes.

Authors:  S L Brandenburg; J E Reusch; T A Bauer; B W Jeffers; W R Hiatt; J G Regensteiner
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

8.  Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.

Authors:  Mihaela Tanasescu; Michael F Leitzmann; Eric B Rimm; Frank B Hu
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

9.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

Review 10.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015
View more
  233 in total

1.  Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes.

Authors:  Alejandra Planas; Olga Simó-Servat; Jordi Bañeras; Mónica Sánchez; Esther García; Ángel M Ortiz; Marisol Ruiz-Meana; Cristina Hernández; Ignacio Ferreira-González; Rafael Simó
Journal:  Acta Diabetol       Date:  2021-05-25       Impact factor: 4.280

Review 2.  Quality of Diabetes Care in the USA.

Authors:  Ben Alencherry; Dennis Bruemmer
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

3.  Receptor for advanced glycation end products gene polymorphisms in cardiac syndrome X.

Authors:  Burak Önal; Deniz Özen; Bülent Demir; Ahmet G Akkan; Sibel Özyazgan
Journal:  Biomed Rep       Date:  2019-07-22

4.  Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Colomba Falcone
Journal:  Ann Transl Med       Date:  2018-05

5.  Aortic Augmentation Index is Dependent on Bodyside in Healthy Young Subjects.

Authors:  Sandra Einstein; Kristjan Pilt; Merlin Palmar; Kalju Meigas; Margus Viigimaa
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-08-16

6.  Comparing the influence of 2009 versus 2016 ASE/EACVI diastolic function guidelines on the prevalence and echocardiographic characteristics of preclinical diastolic dysfunction (stage B heart failure) in a Hispanic population with type 2 diabetes mellitus.

Authors:  Siu-Hin Wan; Andrew S Pumerantz; Fanglong Dong; Cesar Ochoa; Horng H Chen
Journal:  J Diabetes Complications       Date:  2019-05-07       Impact factor: 2.852

Review 7.  An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.

Authors:  Anil N Makam; Oanh K Nguyen
Journal:  Circulation       Date:  2017-01-10       Impact factor: 29.690

8.  Sex differences in endothelial function in chronic kidney disease.

Authors:  Nicholas T Kruse; Zhiying You; Kerrie Moreau; Jessica Kendrick; Diana Jalal
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-18

9.  Estrogen-dependent hypersensitivity to diabetes-evoked cardiac autonomic dysregulation: Role of hypothalamic neuroinflammation.

Authors:  Mohamed A Fouda; Korin E Leffler; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2020-03-31       Impact factor: 5.037

10.  Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Authors:  Sylwia M Figarska; Stefan Gustafsson; Johan Sundström; Johan Ärnlöv; Anders Mälarstig; Sölve Elmståhl; Tove Fall; Lars Lind; Erik Ingelsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.